Ceribell, Inc.
Ceribell, Inc. (Nasdaq: CBLL) is a medical technology company that develops point-of-care EEG systems for diagnosing and monitoring serious neurological conditions, initially focusing on seizures in acute care settings. Its Ceribell System combines disposable headbands and headcaps, a portable recorder that captures… From the company’s description.
Over the twelve months to Sep 30, 2026, Ceribell, Inc. reported revenue of $108.72M, up 31.3% from a year earlier, and a net loss of $73.88M. Its operating margin was −69.8%, and operations used $56.01M in cash. In fiscal 2025, it reported revenue of $89.06M, up 36.1% from fiscal 2024, and a net loss of $53.41M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Ceribell, Inc. does
In the company’s own words
Ceribell, Inc. (Nasdaq: CBLL) is a medical technology company that develops point-of-care EEG systems for diagnosing and monitoring serious neurological conditions, initially focusing on seizures in acute care settings. Its Ceribell System combines disposable headbands and headcaps, a portable recorder that captures and wirelessly transmits EEG signals, a web-based portal for remote access, and AI-powered algorithms that support clinicians’ assessment of seizure activity. The company’s products serve hospitals and their clinicians, including bedside healthcare professionals and neurologists; its system is also cleared for delirium monitoring and for seizure detection in pediatric patients and neonates. Ceribell generates recurring revenue from sales of single-patient-use Wearables and monthly subscriptions for Clarity, recorders, and the portal. As of December 31, 2025, the system had been adopted by more than 600 hospitals, and the company had 327 employees. Revenue for the year ended December 31, 2025, was $89.1 million.
Company details
- Sector
- Health Care
- Industry (SIC)
- Electromedical Apparatus
- Headquarters
- SUNNYVALE, CA
- Fiscal year end
- December
- CIK
- 1861107
- SIC
- 3845
Financial performance, year by year
Fiscal 2024–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Ceribell, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Ceribell, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Ceribell, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Ceribell, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Ceribell, Inc.'s last four quarterly filings that the numbers alone won't show?”